Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
501.70Prev. Close
502.00Volume
56,190Total traded value
2.76 CrUpper Circuit
589.30Lower Circuit
392.90Fundamentals
| Market Cap | ₹4,511Cr |
| ROE | 12.28% |
| P/E Ratio(TTM) | 23.89 |
| EPS(TTM) | 20.54 |
| P/B Ratio | 3.29 |
| Dividend Yield | 0.20% |
| Industry P/E | 34.85 |
| Book Value | 148.98 |
| Debt to Equity | 0.45 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Aarti Drugs
Aarti Drugs Limited is a leading pharmaceutical company that specialises in manufacturing active pharmaceutical ingredients (APIs), speciality chemicals, and intermediates for various medicines worldwide. The company's vision is to be the preferred vendor of bulk drugs by ensuring consistent quality and timely delivery at competitive prices. The company has an extensive global presence, operating across six continents and spanning over 100 countries.;
| Parent Organisation | Aarti Drugs Limited |
| Managing Director | Shri. Rashesh Gogri |
| NSE Symbol | AARTIDRUGS |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(3)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 77.66 | ||
| Neuland Laboratories | NA (0.00%) | 120.30 | ||
| Jubilant Pharmova | NA (0.00%) | 36.86 | ||
| Acutaas Chemicals | NA (0.00%) | 62.52 |